A modern approach to the treatment of plaque psoriasis
Psoriasis is a common chronic inflammatory skin disease which affects 0.5–1 % of children and 2–3 % of the adult population. In Croatia, 1.6 % of the population suffer from psoriasis. Distribution of the disease is bimodal, with the first peak at the age of 20–30, and the second at the age of 50–60....
Saved in:
Main Authors: | Drvar Daniela Ledić, Vlahinić Tomislav, Maleš Željan, Turčić Petra, Čeović Romana |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-12-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2019-0047 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gender-related Therapeutical Response to Apremilast: New Insights in a Tailored Management of Psoriasis
by: Emanuele Trovato, et al.
Published: (2025-01-01) -
Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01) -
Application of medicinal plants in several dermatovenerological entities
by: Maleš Željan, et al.
Published: (2019-12-01) -
Managing pediatric psoriasis: update on treatments and challenges—a review
by: A. A. Hebert, et al.
Published: (2022-07-01) -
Real-life Experience of Bimekizumab in 27 Obese Patients With Plaque-type Psoriasis: a 24-week Multicenter Retrospective Study
by: Zeno Fratton, et al.
Published: (2025-01-01)